| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39770248238389dd869fdaef87983879 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46018b5b4d258358baf325394c93990b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30ddd377eb28407e555d3615591a43ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef459182bd9703b1290343eb33573a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a8fdf5d4ead170d215073da873b92c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78caef3a749713a79fdb397fd10669c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15628e42dca411ce1ba3e753d5ad4383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1499ccb66dc05669b916fd52dd5f70 |
| publicationDate |
2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017028044-A1 |
| titleOfInvention |
Compositions And Methods For Viral Cancer Neoepitopes |
| abstract |
Methods and compositions for preparation and use of recombinant viruses or other recombinant expression systems are presented in which neoepitopes are first identified in a patient- and cancer-specific manner and then further filtered by HLA-match to the patient. Selected neoepitopes are then expression using sequence elements that direct the expressed neoepitope to the HLA-type (MHC-I and/or MHC-II subtype) that has desirable affinity to the filtered neoepitope. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11183286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019104270-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771747-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018204377-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111417648-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11264117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019226939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019279742-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113215253-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111465695-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591619-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016309319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021244658-A1 |
| priorityDate |
2015-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |